Dietary therapy for children with ADHD;Nährstofftherapie bei AD(H)S

Deutsche Apotheker Zeitung

Volumn 145, Issue 24, 2005, Pages 54-57

  Doebel, Jutta ^b   Keller, Georg ^a   Zierau, Marie Therese ^b  

^a Apothekerkammer Nordrhein   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ATOMOXETINE; DOCOSAHEXAENOIC ACID; DOPAMINE; EQUASYM; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; MAGNESIUM; MEDIKINET; METHYLPHENIDATE; NORADRENALIN; OMEGA 3 FATTY ACID; PSYCHOSTIMULANT AGENT; SEROTONIN; ZINC;

ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; CHILD NUTRITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET SUPPLEMENTATION; DIET THERAPY; DOUBLE BLIND PROCEDURE; HUMAN; HYPERACTIVITY; INTERNATIONAL CLASSIFICATION OF DISEASES; KETOGENIC DIET; NEUROTRANSMISSION; PHASE 2 CLINICAL TRIAL; PREVALENCE; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 21344459048     PISSN: 00119857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Fegert, Glaeske, Janhsen, Ludolph, Ronge: Untersuchung zur Arzneimittel-Versorgung von Kindern mit hyperkinetischen Störungen anhand von Leistungsdaten der GKV. Projektbericht, Universität Bremen und Universitätsklinikum Ulm, Dezember 2002.
2. Döpfner, M: Hyperkinetische Störungen. In F. Petermann (Hrsg.): Lehrbuch der klinischen Kinderpsychologie, 4. Auflage, S. 153-189. Göttingen, 2000.
3. Wenwei, Y.: An Investigation of adult outcome of hyperactive Children in Shanghai. Chin. Med. J. 109, 877-880 (1996).
4. ICD 10 = International Statistical Classification of Diseases and Related Health Problems, 10. Revision, WHO; DSM IV = Diagnostic and Statistical Manual of Mental Disorders, 4. Edition, American Psychiatric Association.
5. Skrodzki, K.: Das Hyperkinetische Syndrom, zitiert in Schulz, J.: ADHS, das "Zappelphilipp-Syndrom" - Ursachen und therapeutische Möglichkeiten, Naturheilpraxis 55, 1572 (2002).
6. Bennett, H.: Gene targets related to phospholipid and fatty acid metabolism in schizophrenia and other psychiatric disorders: an update. Prostaglandins Leukot. Essent. Fatty Acids 63, 47-59 (2000).
7. Krause, J., Krause, K.-H.: ADHS im Erwachsenenalter. Die Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen. Stuttgart 2003.
8. Holsboer-Trachsler, Vanoni: Depression und Schlafstörung in der Praxis. Binningen, 1998.
9. Hibbeln, J.R., et al.: Essential Fatty Acids Predict Metabolites of Serotonin and Dopamin in Cerebrospinal Fluid among Healthy Control Subjects, and Early- and Late-Onset Alcoholics. Biol. Psychiatry 44, 235-242 (1998).
10. Burgess, Stevens, Zhang, Peck: Long-chain polyunsaturated fatty acids in children with attention-deficite hyperactivity disorder. Am. J. Clin. Nutr. 71, 327-330 (2000).
11. Arnold, Pinkham, Votolato: Does zinc moderate Essential fatty Acid and Amphetamin Treatment of Attention-Deficit/Hyperactivity Disorder? J. Child Adolesc. Psychopharmacol. 10, 111-117 (2000).
12. Burgess: Attention deficit hyperactivity disorder: observational and interventional studies. NIH workshop on omega-3- essential fatty acids and psychiatric disorders. National Institutes of Health, Bethesda, 1998, Sep. 2-3.
13. Horrobin, C.: Interactions between Zink, essential fatty acids and prostaglandines. Med. Hypoth. 6, 277-296 (1980).
14. Starobrat-Hermelin, K.: The effects of magnesium physiological supplementation on hyperactivity in children with Attention Deficit Hyperactivity Disorder (ADHD). Positive Response to magnesium oral loading test. Magnesium Res. 10, 149-156 (1997).
15. Akhondzadeh, et al.: Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children. A double blind and randomized trial. BMC Psychiatry 4, 9 (2004).
16. Richardson, A.J., Puri, B.K.: A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 233-239 (2002).
17. Schmidt, et al.: Effect of dextroamphetamine and methylphenidate on calcium and magnesium concentration in hyperactive boys. Psychiatric Res. 54, 199-210 (1994).
18. (war): Hoffnung für Patienten mit schweren Depressionen? Dtsch. Apoth. Ztg. 145, 821-822 (2005).
19. Baumeister, F.A.M., et al.: Die Ketogene Diät, Renaissance einer vergessenen Therapie, Kinder Jugendmed. 3, 76-81 und 120-126 (2003).